Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mitomycin 10mg powder for solution for injection vials
0801020Q0AAAFAF
|
Mitomycin | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin 20mg powder for solution for injection vials
0801020Q0AAAGAG
|
Mitomycin | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin 2mg powder for solution for injection vials
0801020Q0AAAEAE
|
Mitomycin | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin 40mg powder for intravesical solution vials
0801020Q0AAADAD
|
Mitomycin | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin-C Kyowa 10mg inj vials
0801020Q0BBABAF
|
Mitomycin-C Kyowa | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin-C Kyowa 20mg inj vials
0801020Q0BBACAG
|
Mitomycin-C Kyowa | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin-C Kyowa 2mg inj vials
0801020Q0BBAAAE
|
Mitomycin-C Kyowa | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin-C Kyowa 40mg pdr for intravesical solution vials
0801020Q0BBADAD
|
Mitomycin-C Kyowa | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitoxana 1g powder for solution for injection vials
0801010N0BBABAB
|
Mitoxana | Ifosfamide | Malignant Disease and Immunosuppression | No data available |
|
Mitoxana 2g powder for solution for injection vials
0801010N0BBACAC
|
Mitoxana | Ifosfamide | Malignant Disease and Immunosuppression | No data available |
|
Mitoxantrone 10mg/5ml solution for infusion vials
0801020R0AAAEAE
|
Mitoxantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Mitoxantrone 20mg/10ml solution for infusion vials
0801020R0AAAAAA
|
Mitoxantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Mitoxantrone 25mg/12.5ml solution for infusion vials
0801020R0AAABAB
|
Mitoxantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Mitoxantrone 30mg/15ml solution for infusion vials
0801020R0AAACAC
|
Mitoxantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Mivacron 10mg/5ml solution for injection ampoules
1501050K0BBAAAA
|
Mivacron | Mivacurium chloride | Anaesthesia | No data available |
|
Mivacron 20mg/10ml solution for injection ampoules
1501050K0BBABAB
|
Mivacron | Mivacurium chloride | Anaesthesia | No data available |
|
Mivacurium chloride 10mg/5ml solution for injection ampoules
1501050K0AAAAAA
|
Mivacurium chloride | Mivacurium chloride | Anaesthesia | No data available |
|
Mivacurium chloride 20mg/10ml inj ampoules
1501050K0AAABAB
|
Mivacurium chloride | Mivacurium chloride | Anaesthesia | No data available |
|
Mixtard 10 NovoLet 100units/ml suspension for injection
0601012D0BCASBQ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 10 Penfill 100units/ml inj 3ml cartridges
0601012D0BCAYBI
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 20 NovoLet 100units/ml suspension for injection
0601012D0BCATA3
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 20 Penfill 100units/ml inj 3ml cartridges
0601012D0BCAZAZ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 30 100units/ml suspension for injection 10ml vials
0601012D0BCAWAG
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 30 InnoLet 100units/ml inj 3ml pre-filled pens
0601012D0BCBDBZ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 30 NovoLet 100units/ml suspension for injection
0601012D0BCARBZ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.